Robert Nelsen - 20 Dec 2021 Form 4/A - Amendment Insider Report for Vir Biotechnology, Inc. (VIR)

Role: Director, 10%+ Owner
Signature: By: Robert Nelsen, Managing Director, By: /s/ Mark McDonnell, as Attorney-in-Fact
Issuer symbol: VIR
Transactions as of: 20 Dec 2021
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 10 May 2022, 17:26:42 UTC
Date Of Original Report: 22 Dec 2021
Previous filing: 01 Dec 2021
Next filing: 06 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Other	$0	+102,041	+70%	$0.000000	247,546	20 Dec 2021	Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Distribution of Common Stock held by a limited partnership to its partners for no consideration.
F2	Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person.
F3	Correction made to include shares previously reported in prior filing on 5/21/21 but not included in the amount of shares beneficially owned in subsequent filings.